- 1. Introduction
- 1.1. Market Definition
- 1.2. Market Ecosystem
- 1.3. Currency
- 1.4. Key Stakeholders
- 2. Research Methodology
- 2.1. Research Process
- 2.2. Data Collection & Validation
- 2.2.1. Secondary Research
- 2.2.2. Primary Research
- 2.3. Market Assessment
- 2.3.1. Market Size Estimation
- 2.3.1.1. Bottom-up Approach
- 2.3.1.2. Top-down Approach
- 2.3.1.3. Growth Forecast
- 2.3.2. Market Share Analysis
- 2.4. Assumptions for the Study
- 2.5. Limitations for the Study
- 3. Executive Summary
- 4. Market Insights
- 4.1. Introduction
- 4.2. Drivers
- 4.2.1. Growing Therapeutic Applications of Pharmacogenomics Biomarkers
- 4.2.2. Increasing Adoption of Personalized Medicine
- 4.2.3. Increasing Geriatric Population and Chronic Disease Prevalence
- 4.2.4. Growing Awareness of Adverse Drug Reactions
- 4.3. Restraints
- 4.3.1. High Cost of Personalized Medicine
- 4.3.2. Lack of Reimbursement for Genetic Testing & Precision Medicine
- 4.4. Opportunities
- 4.4.1. Increasing Application of Pharmacogenomics in Neurological Disorders and Cancer
- 4.4.2. Development of New, More Advanced, and Accurate Diagnostic Tools
- 4.5. Challenges
- 4.5.1. Low Awareness of Pharmacogenomics/Personalized Medicine among People
- 4.5.2. Knowledge Gap about Genetic Testing and its Benefits
- 4.6. Impact Analysis of COVID-19
- 5. Global Pharmacogenomics Market, by Technology
- 5.1. Introduction
- 5.2. Polymerase Chain Reaction
- 5.3. DNA Sequencing
- 5.4. Electrophoresis
- 5.5. Microarray
- 5.6. Mass Spectrometry
- 5.7. Other Technologies
- 6. Global Pharmacogenomics Market, by Application
- 6.1. Introduction
- 6.2. Oncology
- 6.3. Cardiology
- 6.4. Neurologic Diseases
- 6.5. Infectious Diseases
- 6.6. Other Applications
- 7. Global Pharmacogenomics Market, by End User
- 7.1. Introduction
- 7.2. Hospitals
- 7.3. Diagnostic Laboratories
- 7.4. Academic & Research Institutions
- 7.5. Other End Users
- 8. Pharmacogenomics Market, by Geography
- 8.1. Introduction
- 8.2. North America
- 8.2.1. U.S.
- 8.2.2. Canada
- 8.3. Europe
- 8.3.1. Germany
- 8.3.2. U.K.
- 8.3.3. France
- 8.3.4. Spain
- 8.3.5. Italy
- 8.3.6. Rest of Europe (RoE)
- 8.4. Asia-Pacific
- 8.4.1. China
- 8.4.2. Japan
- 8.4.3. India
- 8.4.4. Rest of Asia-Pacific (RoAPAC)
- 8.5. Latin America
- 8.5.1. Brazil
- 8.5.2. Mexico
- 8.5.3. Rest of Latin America (RoLATAM)
- 8.6. Middle East & Africa
- 9. Competitive Landscape
- 9.1. Introduction
- 9.2. Key Growth Strategies
- 9.3. Competitive Benchmarking
- 10. Company Profiles (Business Overview, Financial Snapshot, Product Benchmarking, and Strategic Developments)
- 10.1. F. Hoffmann-La Roche Ltd
- 10.2. Abbott Laboratories
- 10.3. Thermo Fisher Scientific Inc.
- 10.4. Agilent Technologies, Inc.
- 10.5. Illumina, Inc.
- 10.6. OPKO Health, Inc.
- 10.7. Dynamic DNA Laboratories
- 10.8. Admera Health
- 10.9. Qiagen N.V.
- 10.10. Myriad Genetics, Inc.
- 11. Appendix
- 11.1. Questionnaire
- 11.2. Available Customization
List of Tables
Table 1 Global Pharmacogenomics Market Drivers: Impact Analysis (2022–2029)
Table 2 Global Pharmacogenomics Market Restraints: Impact Analysis (2022–2029)
Table 3 Global Pharmacogenomics Market Size, by Technology, 2020–2029 (USD Million)
Table 4 Global Pharmacogenomics Market Size for Polymerase Chain Reaction, by Country/Region, 2020–2029 (USD Million)
Table 5 Global Pharmacogenomics Market Size for DNA Sequencing, by Country/Region, 2020–2029 (USD Million)
Table 6 Global Pharmacogenomics Market Size for Electrophoresis, by Country/Region, 2020–2029 (USD Million)
Table 7 Global Pharmacogenomics Market Size for Microarray, by Country/Region, 2020–2029 (USD Million)
Table 8 Global Pharmacogenomics Market Size for Mass Spectrometry, by Country/Region, 2020–2029 (USD Million)
Table 9 Global Pharmacogenomics Market Size for Other Technologies, by Country/Region, 2020–2029 (USD Million)
Table 10 Global Pharmacogenomics Market Size, by Application, 2020–2029 (USD Million)
Table 11 Global Pharmacogenomics Market Size for Oncology, by Country/Region, 2020–2029 (USD Million)
Table 12 Global Pharmacogenomics Market Size for Cardiology, by Country/Region, 2020–2029 (USD Million)
Table 13 Global Pharmacogenomics Market Size for Neurologic Diseases, by Country/Region, 2020–2029 (USD Million)
Table 14 Global Pharmacogenomics Market Size for Infectious Diseases, by Country/Region, 2020–2029 (USD Million)
Table 15 Global Pharmacogenomics Market Size for Other Applications, by Country/Region, 2020–2029 (USD Million)
Table 16 Global Pharmacogenomics Market Size, by End User, 2020–2029 (USD Million)
Table 17 Global Pharmacogenomics Market Size for Hospitals, by Country/Region, 2020–2029 (USD Million)
Table 18 Global Pharmacogenomics Market Size for Diagnostic Laboratories, by Country/Region, 2020–2029 (USD Million)
Table 19 Global Pharmacogenomics Market Size for Academic and Research Institutes, by Country/Region, 2020–2029 (USD Million)
Table 20 Global Pharmacogenomics Market Size for Other End Users, by Country/Region, 2020–2029 (USD Million)
Table 21 Global Pharmacogenomics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 22 North America: Pharmacogenomics Market Size, by Country, 2020–2029 (USD Million)
Table 23 North America: Pharmacogenomics Market Size, by Technology, 2020–2029 (USD Million)
Table 24 North America: Pharmacogenomics Market Size, by Application, 2020–2029 (USD Million)
Table 25 North America: Pharmacogenomics Market Size, by End User, 2020–2029 (USD Million)
Table 26 U.S.: Pharmacogenomics Market Size, by Technology, 2020–2029 (USD Million)
Table 27 U.S.: Pharmacogenomics Market Size, by Application, 2020–2029 (USD Million)
Table 28 U.S.: Pharmacogenomics Market Size, by End User, 2020–2029 (USD Million)
Table 29 Canada: Pharmacogenomics Market Size, by Technology, 2020–2029 (USD Million)
Table 30 Canada: Pharmacogenomics Market Size, by Application, 2020–2029 (USD Million)
Table 31 Canada: Pharmacogenomics Market Size, by End User, 2020–2029 (USD Million)
Table 32 Europe: Pharmacogenomics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 33 Europe: Pharmacogenomics Market Size, by Technology, 2020–2029 (USD Million)
Table 34 Europe: Pharmacogenomics Market Size, by Application, 2020–2029 (USD Million)
Table 35 Europe: Pharmacogenomics Market Size, by End User, 2020–2029 (USD Million)
Table 36 U.K.: Pharmacogenomics Market Size, by Technology, 2020–2029 (USD Million)
Table 37 U.K.: Pharmacogenomics Market Size, by Application, 2020–2029 (USD Million)
Table 38 U.K.: Pharmacogenomics Market Size, by End User, 2020–2029 (USD Million)
Table 39 Germany: Pharmacogenomics Market Size, by Technology, 2020–2029 (USD Million)
Table 40 Germany: Pharmacogenomics Market Size, by Application, 2020–2029 (USD Million)
Table 41 Germany: Pharmacogenomics Market Size, by End User, 2020–2029 (USD Million)
Table 42 France: Pharmacogenomics Market Size, by Technology, 2020–2029 (USD Million)
Table 43 France: Pharmacogenomics Market Size, by Application, 2020–2029 (USD Million)
Table 44 France: Pharmacogenomics Market Size, by End User, 2020–2029 (USD Million)
Table 45 Spain: Pharmacogenomics Market Size, by Technology, 2020–2029 (USD Million)
Table 46 Spain: Pharmacogenomics Market Size, by Application, 2020–2029 (USD Million)
Table 47 Spain: Pharmacogenomics Market Size, by End User, 2020–2029 (USD Million)
Table 48 Italy: Pharmacogenomics Market Size, by Technology, 2020–2029 (USD Million)
Table 49 Italy: Pharmacogenomics Market Size, by Application, 2020–2029 (USD Million)
Table 50 Italy: Pharmacogenomics Market Size, by End User, 2020–2029 (USD Million)
Table 51 Rest of Europe: Pharmacogenomics Market Size, by Technology, 2020–2029 (USD Million)
Table 52 Rest of Europe: Pharmacogenomics Market Size, by Application, 2020–2029 (USD Million)
Table 53 Rest of Europe: Pharmacogenomics Market Size, by End User, 2020–2029 (USD Million)
Table 54 Asia-Pacific: Pharmacogenomics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 55 Asia-Pacific: Pharmacogenomics Market Size, by Technology, 2020–2029 (USD Million)
Table 56 Asia-Pacific: Pharmacogenomics Market Size, by Application, 2020–2029 (USD Million)
Table 57 Asia-Pacific: Pharmacogenomics Market Size, by End User, 2020–2029 (USD Million)
Table 58 Japan: Pharmacogenomics Market Size, by Technology, 2020–2029 (USD Million)
Table 59 Japan: Pharmacogenomics Market Size, by Application, 2020–2029 (USD Million)
Table 60 Japan: Pharmacogenomics Market Size, by End User, 2020–2029 (USD Million)
Table 61 China: Pharmacogenomics Market Size, by Technology, 2020–2029 (USD Million)
Table 62 China: Pharmacogenomics Market Size, by Application, 2020–2029 (USD Million)
Table 63 China: Pharmacogenomics Market Size, by End User, 2020–2029 (USD Million)
Table 64 India: Pharmacogenomics Market Size, by Technology, 2020–2029 (USD Million)
Table 65 India: Pharmacogenomics Market Size, by Application, 2020–2029 (USD Million)
Table 66 India: Pharmacogenomics Market Size, by End User, 2020–2029 (USD Million)
Table 67 Rest of Asia-Pacific: Pharmacogenomics Market Size, by Technology, 2020–2029 (USD Million)
Table 68 Rest of Asia-Pacific: Pharmacogenomics Market Size, by Application, 2020–2029 (USD Million)
Table 69 Rest of Asia-Pacific: Pharmacogenomics Market Size, by End User, 2020–2029 (USD Million)
Table 70 Latin America: Pharmacogenomics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 71 Latin America: Pharmacogenomics Market Size, by Technology, 2020–2029 (USD Million)
Table 72 Latin America: Pharmacogenomics Market Size, by Application, 2020–2029 (USD Million)
Table 73 Latin America: Pharmacogenomics Market Size, by End User, 2020–2029 (USD Million)
Table 74 Brazil: Pharmacogenomics Market Size, by Technology, 2020–2029 (USD Million)
Table 75 Brazil: Pharmacogenomics Market Size, by Application, 2020–2029 (USD Million)
Table 76 Brazil: Pharmacogenomics Market Size, by End User, 2020–2029 (USD Million)
Table 77 Mexico: Pharmacogenomics Market Size, by Technology, 2020–2029 (USD Million)
Table 78 Mexico: Pharmacogenomics Market Size, by Application, 2020–2029 (USD Million)
Table 79 Mexico: Pharmacogenomics Market Size, by End User, 2020–2029 (USD Million)
Table 80 Rest of Latin America: Pharmacogenomics Market Size, by Technology, 2020–2029 (USD Million)
Table 81 Rest of Latin America: Pharmacogenomics Market Size, by Application, 2020–2029 (USD Million)
Table 82 Rest of Latin America: Pharmacogenomics Market Size, by End User, 2020–2029 (USD Million)
Table 83 Middle East & Africa: Pharmacogenomics Market Size, by Technology, 2020–2029 (USD Million)
Table 84 Middle East & Africa: Pharmacogenomics Market Size, by Application, 2020–2029 (USD Million)
Table 85 Middle East & Africa: Pharmacogenomics Market Size, by End User, 2020–2029 (USD Million)
Table 86 Recent Developments, by Company, 2020–2022
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Size Estimation
Figure 7 Market Dynamics
Figure 8 Global Pharmacogenomics Market Size, by Technology, 2022 Vs. 2029 (USD Million)
Figure 9 Global Pharmacogenomics Market Size, by Application, 2022 Vs. 2029 (USD Million)
Figure 10 Global Pharmacogenomics Market Size, by End User, 2022 Vs. 2029 (USD Million)
Figure 11 Global Pharmacogenomics Market, by Geography
Figure 12 North America: Pharmacogenomics Market Snapshot
Figure 13 Europe: Pharmacogenomics Market Snapshot
Figure 14 Asia-Pacific: Pharmacogenomics Market Snapshot
Figure 15 Latin America: Pharmacogenomics Market Snapshot
Figure 16 Key Growth Strategies Adopted by Leading Players, 2020–2022
Figure 17 Pharmacogenomics Market: Competitive Benchmarking (Based on Technology)
Figure 18 Pharmacogenomics Market: Competitive Benchmarking (Based on Geography)
Figure 19 F. Hoffman-La Roche Ltd: Financial Snapshot (2021)
Figure 20 Thermo Fisher Scientific Inc.: Financial Snapshot (2021)
Figure 21 Agilent Technologies, Inc.: Financial Snapshot (2021)
Figure 22 Illumina, Inc.: Financial Snapshot (2021)
Figure 23 Qiagen N.V.: Financial Snapshot (2021)
Figure 24 Myriad Genetics, Inc.: Financial Snapshot (2021)
Figure 25 OPKO Health, Inc.: Financial Snapshot (2021)
COVID-19
This report provides pre & post COVID-19 market estimates.